Cargando…
Cytochrome P450 CYP1B1 Interacts with 8-Methoxypsoralen (8-MOP) and Influences Psoralen-Ultraviolet A (PUVA) Sensitivity
BACKGROUND: There are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that variability in cutaneous P450 expression ma...
Autores principales: | Deeni, Yusuf Y., Ibbotson, Sally H., Woods, Julie A., Wolf, C. Roland, Smith, Gillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781062/ https://www.ncbi.nlm.nih.gov/pubmed/24086543 http://dx.doi.org/10.1371/journal.pone.0075494 |
Ejemplares similares
-
Psoralen plus ultraviolet A (PUVA) soaks and UVB TL01 treatment for chronic hand dermatoses
por: Jensen, Lisbeth, et al.
Publicado: (2012) -
Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
por: Castillo-Aleman, Yandy Marx
Publicado: (2022) -
8-Methoxypsoralen is a competitive inhibitor of glutathione S-transferase P1-1
por: de Oliveira, Diêgo Madureira, et al.
Publicado: (2014) -
Psoralen-ultraviolet A treatment with Psoralen-ultraviolet B therapy in the treatment of psoriasis
por: Ahmed Asim, Sadaf, et al.
Publicado: (2013) -
Specific transcriptional responses induced by 8-methoxypsoralen and UVA in yeast
por: Dardalhon, Michèle, et al.
Publicado: (2007)